Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

James Rolke Insider Profile

11 Followers

James Rolke, CEO, Director at Revelation Biosciences, holds 422.81K shares in Revelation Biosciences (Ticker: REVB), holds 81.77K shares in La Jolla Pharma (Ticker: LJPC).

James Rolke's Trading History

REVBRevelation Biosciences		Aug 18, 2026CEO, DirectorUninformative Buy―$1.70M
LJPCLa Jolla Pharma		Jun 02, 2020―Uninformative Buy822.05$508.62K
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

James Rolke insider profile FAQ

What is the percentage of profitable transactions made by James Rolke?
The percentage of profitable transactions made by James Rolke is 0%.
What is the average return per transaction made by James Rolke?
The average return per transaction made by James Rolke is -34.90%.
What stocks does James Rolke hold?
James Rolke holds: REVB, LJPC stocks.
What was James Rolke's most profitable transaction?
James Rolke’s most profitable transaction was an Informative Buy of LJPC stock on January 9, 2019. The return on the trade was -13.70%.
What is James Rolke's role in Revelation Biosciences?
James Rolke's role in Revelation Biosciences is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.